Home > News

 

 

ARCHIVE NEWS
Chiesi’s new interim CEO
16 December 2022
From cells to packaging
29 December 2022
Energize Programme: a shared commitment to accelerate the adoption of renewable energy in the pharmaceutical sector
17 November 2022
“Vendor Day”: the role of Chiesi Group’s Value Chain in shaping the future
16 November 2022
Chiesi recognized by Biden Administration for its support and commitment to greater resilience in the fight against climate change
14 November 2022
Fostering innovation for rare diseases in Europe: Chiesi supports the RDR Challenges Call
27 October 2022
Giacomo Chiesi awarded by PharmaVoice100
09 September 2022
A new EU proposal to protect people and planet by reducing F-gases
01 August 2022
Chiesi Group joins Biden Administration pledge to decarbonize healthcare sector
06 July 2022
New record for Chiesi Group: in 2021 it’s confirmed top Italian pharmaceutical company for number of patents filed
28 April 2022
© 2025 CHIESI Farmaceutici S.p.A.
VAT IT 01513360345
Company's Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271

PHARMACOVIGILANCE

TO REPORT ADVERSE DRUG EVENTS/REACTIONS PLEASE CLICK HERE


follow us on: